No Data
No Data
PROCEPT BioRobotics Announces Board Chairperson Transition
Express News | Procept Biorobotics Corp : Leerink Partners Raises Target Price to $77 From $74
A Closer Look at 4 Analyst Recommendations For PROCEPT BioRobotics
4 analysts have expressed a variety of opinions on PROCEPT BioRobotics (NASDAQ:PRCT) over the past quarter, offering a diverse set of opinions from bullish to bearish.Summarizing their recent
Truist Financial Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Announces Target Price $79
Truist Financial analyst Richard Newitter maintains $PROCEPT BioRobotics(PRCT.US)$ with a buy rating, and sets the target price at $79.According to TipRanks data, the analyst has a success rate of 58.
Truist Securities Maintains Buy on PROCEPT BioRobotics, Raises Price Target to $79
Truist Securities analyst Richard Newitter maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and raises the price target from $72 to $79.
PROCEPT BioRobotics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/16/2024 17.04% Truist Securities $72 → $79 Maintains Buy 05/06/2024 11.11% TD Cowen $65 → $75
No Data